To study the effect of grivabasti and sthanik abhyang swedan in manya stambh

A comparative randomised openlabel clinical study of grivabasti and sthanik abhyang swedan with aswagandha tail in the management of manyastambh w.s.r. to cervical spondylosis - A comparative Randomised openlabel clinical study of grivabasti and sthanik abhyang swedan with aswagandha tail in the management of manyastambh w.s.r to cervical spondylosis.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/02/049680

Enrollment

Registered

2023-02-13

Start date

Unknown

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M953- Acquired deformity of neck

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: • Patients presenting with clinical features of manya stambha. • Patients aged between 20-70 years with irrespective of gender. • Patient willing to participate in trial.

Exclusion criteria

Exclusion criteria: • Patient with age group below 20 & above 70 years. • Patient related to spine degeneration other than manyastambha. • Patient having any acute or chronic infectiom or disease like rheumatoid arthritis, SLE, ankylosing spondylitis, DM, HTN, TB of bones hepatic, renal & cardiac failure. • Patient who are not willing for clinical trial.

Design outcomes

Primary

Measure	Time frame
significant relief in pain in the patients of manyastambhTimepoint: At baseline day and after completion of trial.	—

Secondary

Measure	Time frame
significant relief in shool,stambh, sparshasahtva and supti in the patient of manyastambhTimepoint: at baseline day and after completion of trail	—

Countries

India

Contacts

Public ContactDr Monika Das

Shubhdeep Ayurved Medical College

dasmonika16@gmail.com9425320769

Outcome results